Patent details

Basic Information

Publication number:

EP1954252

PCT Application Number:

PCT/US/2006/046212

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP068517812

PCT Publication Number:

WO/2008/051245

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NANOPARTICLES FOR USE IN IMMUNOGENIC COMPOSITIONS

French Title of Invention:

NANOPARTICULES DESTINEES A ETRE UTILISEES DANS DES COMPOSITIONS IMMUNOGENES

German Title of Invention:

NANOPARTIKEL FÜR DEN EINSATZ IN IMMUNOGENEN ZUSAMMENSETZUNGEN

SPC Number:

Dates

Filing date:

01/12/2006

Grant date:

03/02/2016

EP Publication Date:

03/02/2016

PCT Publication Date:

02/05/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/08/2008

EP B1 Publication Date:

03/02/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

01/12/2016

Expiration date:

01/12/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/12/2006

 

 

Name:

GlaxoSmithKline Biologicals SA

Address:

Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

Inventor

1

Name:

WENDORF Janet R.

Address:

United States (US)

2

Name:

SINGH Manmohan

Address:

United States (US)

3

Name:

O'HAGAN Derek T.

Address:

United States (US)

Priority

1

Priority Number:

741860 P

Priority Date:

02/12/2005

Priority Country:

United States (US)

2

Priority Number:

775265 P

Priority Date:

21/02/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/51;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages